Literature DB >> 32266833

The electronic health record as a clinical trials tool: Opportunities and challenges.

Monica M Bertagnolli1, Brian Anderson2, Andre Quina2, Steven Piantadosi1.   

Abstract

Clinical trials provide evidence essential for progress in health care, and as the complexity of medical care has increased, the demand for such data has dramatically expanded. Conducting clinical trials has also become more complicated, evolving to meet increasing challenges in delivering clinical care and meeting regulatory requirements. Despite this, the general approach to data collection remains the same, requiring that researchers submit clinical data in response to study treatment protocols, using precisely defined data structures made available in study-specific case report forms. Currently, research data management is not integrated within the patient's clinical care record, creating added burden for clinical staff and opportunities for error. During the past decade, the electronic health record has become standard across the US healthcare system and is increasingly used to collect and analyze data reporting quality metrics for clinical care delivery. Recently, electronic health record data have also been used to address clinical research questions; however, this approach has significant drawbacks due to the unstructured and incomplete nature of current electronic health record data. This report describes steps necessary to use the electronic health record as a tool for conducting high-quality clinical research.

Entities:  

Keywords:  Data standards; clinical trials design; electronic health records

Mesh:

Year:  2020        PMID: 32266833     DOI: 10.1177/1740774520913819

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  7 in total

Review 1.  Real-World Data as External Controls: Practical Experience from Notable Marketing Applications of New Therapies.

Authors:  Rima Izem; Joan Buenconsejo; Ruthanna Davi; Jingyu Julia Luan; LaRee Tracy; Margaret Gamalo
Journal:  Ther Innov Regul Sci       Date:  2022-06-08       Impact factor: 1.337

2.  Apples and Oranges? Considerations for EHR-Based Analyses Aggregating Data From Interventional Clinical Trials and Point-of-Care Encounters in Oncology.

Authors:  Jessica A Lavery; Margaret K Callahan; Katherine S Panageas
Journal:  JCO Clin Cancer Inform       Date:  2021-01

3.  GLASS(Y) Half-Full: Moving Towards Greater Pragmatism in Outcome Ascertainment for Clinical Trials.

Authors:  Sanket S Dhruva
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2021-02-04

Review 4.  The ACTTION Guide to Clinical Trials of Pain Treatments, part II: mitigating bias, maximizing value.

Authors:  Robert H Dworkin; Robert D Kerns; Michael P McDermott; Dennis C Turk; Christin Veasley
Journal:  Pain Rep       Date:  2021-01-21

Review 5.  The time is now: role of pragmatic clinical trials in guiding response to global pandemics.

Authors:  Aws Almufleh; Jacob Joseph
Journal:  Trials       Date:  2021-03-24       Impact factor: 2.279

6.  Feasibility of Using Real-world Data to Emulate Postapproval Confirmatory Clinical Trials of Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval.

Authors:  Joshua D Wallach; Audrey D Zhang; Joshua J Skydel; Victoria L Bartlett; Sanket S Dhruva; Nilay D Shah; Joseph S Ross
Journal:  JAMA Netw Open       Date:  2021-11-01

7.  Development of the First Patient-centred Set of Outcomes for Muscle-invasive and Metastatic Bladder Cancer: A Multicentre Initiative.

Authors:  Daan J Reesink; Ewoudt M W van de Garde; Diederik M Somford; Richard P Meijer; Maartje Los; Douwe H Biesma; Simon Horenblas; Harm H E van Melick; Paul B van der Nat
Journal:  Eur Urol Open Sci       Date:  2021-02-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.